Q&A With Raj Kapoor, BMBCh, From University College London Hospital: New Treatment Options for Optic Neuritis Shows 'Exciting' Potential

Video

As part of the overall picture of multiple sclerosis treatment optic neuritis is one of the early stages of the condition. The studies looked at sodium channels that show promise for future multiple sclerosis patients even if it is not in the field.

As part of the overall picture of multiple sclerosis treatment optic neuritis is one of the early stages of the condition. The studies looked at sodium channels that show promise for future multiple sclerosis patients even if it is not in the field.

Raj Kapoor, BMBCh, From University College London Hospital discussed what these developing methods could mean for patient care in the future. With a condition that affects approximately 5 people out of every 100,000 these treatments could provide needed help to a large number of people. Terming these results as "exciting," Kapoor said it is "opening a door," in the field of neural protection.

Related Videos
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
John Kane, MD: Shifts in Antipsychotics for Schizophrenia
© 2024 MJH Life Sciences

All rights reserved.